Innovation for HIV Vaccine Discovery (R01)

Funding Opportunity Number: PAR-16-171
Opportunity Category: Discretionary
Funding Instrument Type: Grant
Category of Funding Activity: Health
CFDA Number: 93.855
Eligible Applicants State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Agency Name: HHS-NIH11
Closing Date: Aug 01, 2016
Award Ceiling:
Expected Number of Awards:
Creation Date: Apr 07, 2016
Funding Opportunity Description: The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing innovative, high risk, high impact research to identify novel HIV vaccine concepts and targets. A further focus is to answer important scientific questions that will aid in the design and development of an effective immunogen that may provide long-term safe protection from either acquisition of, or ongoing infection by HIV. Thus, this FOA aims to support early discovery research by supporting the testing of novel hypotheses and approaches, and the potential for continued funding that is dependent upon achieving applicant-proposed and pre-award negotiated Go/No-Go criterion/criteria by the year-2 progress report.



Please enter your comment!
Please enter your name here